Protein Scaffold‐Based Multimerization of Soluble ACE2 Efficiently Blocks SARS‐CoV‐2 Infection In Vitro and In Vivo
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Protein Scaffold‐Based Multimerization of Soluble ACE2 Efficiently Blocks SARS‐CoV‐2 Infection In Vitro and In Vivo ; day:27 ; month:07 ; year:2022 ; extent:18
Advanced science ; (27.07.2022) (gesamt 18)
- Urheber
-
Kayabolen, Alisan
Akcan, Ugur
Özturan, Doğancan
Ulbegi‐Polat, Hivda
Sahin, Gizem Nur
Pinarbasi‐Degirmenci, Nareg
Bayraktar, Canan
Soyler, Gizem
Sarayloo, Ehsan
Nurtop, Elif
Ozer, Berna
Guney‐Esken, Gulen
Barlas, Tayfun
Yildirim, Ismail Selim
Dogan, Ozlem
Karahuseyinoglu, Sercin
Lack, Nathan A.
Kaya, Mehmet
Albayrak, Cem
Can, Fusun
Solaroglu, Ihsan
Bagci‐Onder, Tugba
- DOI
-
10.1002/advs.202201294
- URN
-
urn:nbn:de:101:1-2022072815091114743051
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:36 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kayabolen, Alisan
- Akcan, Ugur
- Özturan, Doğancan
- Ulbegi‐Polat, Hivda
- Sahin, Gizem Nur
- Pinarbasi‐Degirmenci, Nareg
- Bayraktar, Canan
- Soyler, Gizem
- Sarayloo, Ehsan
- Nurtop, Elif
- Ozer, Berna
- Guney‐Esken, Gulen
- Barlas, Tayfun
- Yildirim, Ismail Selim
- Dogan, Ozlem
- Karahuseyinoglu, Sercin
- Lack, Nathan A.
- Kaya, Mehmet
- Albayrak, Cem
- Can, Fusun
- Solaroglu, Ihsan
- Bagci‐Onder, Tugba
Ähnliche Objekte (12)
Intranasal soluble ACE2 improves organ histopathology and survival in k18hACE2 mice infected with SARS-CoV-2
Human soluble ACE2 improves the effect of remdesivir in SARS‐CoV‐2 infection
Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID19
Elevated soluble ACE2 activity in children and adults after SARS‐CoV‐2 exposure irrespective of laboratory‐confirmed infection
ACE2: the molecular doorway to SARS-CoV-2
Outsmarting SARS-CoV-2 by empowering a decoy ACE2
Clarifying the controversial risk-benefit profile of soluble ACE2 in COVID-19
Age and sex differences in soluble ACE2 may give insights for COVID-19
ACE2-EGFR-MAPK signaling contributes to SARS-CoV-2 infection
Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry
A tethered ligand assay to probe SARS-CoV-2:ACE2 interactions
Multiformin-Type Azaphilones Prevent SARS-CoV-2 Binding to ACE2 Receptor
Intranasal soluble ACE2 improves organ histopathology and survival in k18hACE2 mice infected with SARS-CoV-2
Human soluble ACE2 improves the effect of remdesivir in SARS‐CoV‐2 infection
Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID19
Elevated soluble ACE2 activity in children and adults after SARS‐CoV‐2 exposure irrespective of laboratory‐confirmed infection
ACE2: the molecular doorway to SARS-CoV-2
Outsmarting SARS-CoV-2 by empowering a decoy ACE2
Clarifying the controversial risk-benefit profile of soluble ACE2 in COVID-19
Age and sex differences in soluble ACE2 may give insights for COVID-19
ACE2-EGFR-MAPK signaling contributes to SARS-CoV-2 infection
Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry
A tethered ligand assay to probe SARS-CoV-2:ACE2 interactions
Multiformin-Type Azaphilones Prevent SARS-CoV-2 Binding to ACE2 Receptor
Intranasal soluble ACE2 improves organ histopathology and survival in k18hACE2 mice infected with SARS-CoV-2
Human soluble ACE2 improves the effect of remdesivir in SARS‐CoV‐2 infection
Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID19
Elevated soluble ACE2 activity in children and adults after SARS‐CoV‐2 exposure irrespective of laboratory‐confirmed infection
ACE2: the molecular doorway to SARS-CoV-2
Outsmarting SARS-CoV-2 by empowering a decoy ACE2
Clarifying the controversial risk-benefit profile of soluble ACE2 in COVID-19
Age and sex differences in soluble ACE2 may give insights for COVID-19
ACE2-EGFR-MAPK signaling contributes to SARS-CoV-2 infection
Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry
A tethered ligand assay to probe SARS-CoV-2:ACE2 interactions